Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
15,392,157
-
Total 13F shares
-
13,265,527
-
Share change
-
+1,130,440
-
Total reported value
-
$482,740,723
-
Price per share
-
$36.39
-
Number of holders
-
66
-
Value change
-
+$37,443,874
-
Number of buys
-
40
-
Number of sells
-
29
Institutional Holders of Neurogene Inc. - Common Stock (NGNE) as of Q2 2024
As of 30 Jun 2024,
Neurogene Inc. - Common Stock (NGNE) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,265,527 shares.
The largest 10 holders included
BlackRock Inc., EcoR1 Capital, LLC, Samsara BioCapital, LLC, RTW INVESTMENTS, LP, Redmile Group, LLC, GREAT POINT PARTNERS LLC, JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, VANGUARD GROUP INC, and Casdin Capital, LLC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.